The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 341:50-51 July 1, 1999 Number 1
NextNext

Does Bone Marrow Transplantation Confer a Normal Life Span?

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Socié, G.
-PubMed Citation
In the 1950s and 1960s, many bone marrow transplantations were attempted in terminally ill patients with leukemia or aplastic anemia without success, except in a few patients who had identical-twin donors. The modern era of marrow transplantation began at the end of the 1960s with the development of knowledge about the HLA system and the development of tissue typing. In the 1970s, many patients began to survive the toxic effects of the early preparative regimens and acute graft-versus-host disease. Survival with a successful graft for more than 100 days made it possible to study relapse and chronic graft-versus-host disease. These . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.